- Home
- ENSC vs IMTE Comparison
ENSC vs IMTE Comparison
Compare ENSC & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- IMTE
- Stock Information
- Founded
- ENSC 2003
- IMTE 2008
- Country
- ENSC United States
- IMTE Malaysia
- Employees
- ENSC N/A
- IMTE N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- IMTE Consumer Electronics/Appliances
- Sector
- ENSC Health Care
- IMTE Consumer Staples
- Exchange
- ENSC Nasdaq
- IMTE Nasdaq
- Market Cap
- ENSC 3.4M
- IMTE 4.1M
- IPO Year
- ENSC N/A
- IMTE N/A
- Fundamental
- Price
- ENSC $2.38
- IMTE $1.12
- Analyst Decision
- ENSC
- IMTE
- Analyst Count
- ENSC 0
- IMTE 0
- Target Price
- ENSC N/A
- IMTE N/A
- AVG Volume (30 Days)
- ENSC 455.1K
- IMTE 9.9K
- Earning Date
- ENSC 05-13-2025
- IMTE 06-17-2025
- Dividend Yield
- ENSC N/A
- IMTE N/A
- EPS Growth
- ENSC N/A
- IMTE N/A
- EPS
- ENSC N/A
- IMTE N/A
- Revenue
- ENSC $6,224,081.00
- IMTE $123,337.00
- Revenue This Year
- ENSC N/A
- IMTE N/A
- Revenue Next Year
- ENSC $1,381.48
- IMTE N/A
- P/E Ratio
- ENSC N/A
- IMTE N/A
- Revenue Growth
- ENSC 256.35
- IMTE 4.75
- 52 Week Low
- ENSC $1.62
- IMTE $0.51
- 52 Week High
- ENSC $14.67
- IMTE $3.17
- Technical
- Relative Strength Index (RSI)
- ENSC 49.99
- IMTE 41.83
- Support Level
- ENSC $2.12
- IMTE $1.05
- Resistance Level
- ENSC $2.57
- IMTE $1.13
- Average True Range (ATR)
- ENSC 0.21
- IMTE 0.04
- MACD
- ENSC 0.04
- IMTE -0.00
- Stochastic Oscillator
- ENSC 53.87
- IMTE 35.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.